| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Cediranib (AZD2171) |
|---|
| Description | Cediranib (AZD2171) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less. MW: 450.51. Purity ≥98% |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | AZD2171, Recentin |
|---|
| Gene, Accession, CAS # | CAS: 288383-20-0 |
|---|
| Catalog # | 1613-5 |
|---|
| Price | |
|---|
| Order / More Info | Cediranib (AZD2171) from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|